IC
CEMI

Ikarian Capital’s Chembio diagnostics, Inc. CEMI Stock Holding History

Ikarian Capital’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-219,109
Closed -$769K – 322
2021
Q1 		$769K Hold
219,109
– – 0.03% 245
2020
Q4 		$1.04M Buy
+219,109
New +$1.13M 0.05% 176

Other funds holding CEMI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PM
Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TEE
Tibra Equities Europe London, United Kingdom $90.4M AUM 37.81% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Ikarian Capital's CEMI Position: Q2 2021 in Review

Ikarian Capital sold out of Chembio diagnostics, Inc. (CEMI) in Q2 2021, closing a stake of 219,109 shares — an estimated $769K sold.

Ikarian Capital first reported a position in CEMI in Q4 2020 and held it in 2 quarters. The position peaked at $1.04M in Q4 2020. 60 funds tracked by Wall St. Rank hold CEMI as of Q2 2021.

  • Ikarian Capital reported no remaining Chembio diagnostics, Inc. position as of Q2 2021 after selling out during the quarter.
  • Ikarian Capital sold 219,109 Chembio diagnostics, Inc. shares in Q2 2021, an estimated $769K.
  • Ikarian Capital first reported a position in Chembio diagnostics, Inc. in Q4 2020 and held it in 2 quarters.
  • Ikarian Capital's Chembio diagnostics, Inc. position peaked at $1.04M in Q4 2020.
  • 60 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q2 2021.

Based on Ikarian Capital's 13F filing for Q2 2021, filed 16 Aug 2021.